| A new realistic evaluation analysis method: linked coding of context, mechanism, and outcome relationships SF Jackson, G Kolla American Journal of evaluation 33 (3), 339-349, 2012 | 166 | 2012 |
| ‘It's too much, I'm getting really tired of it’: Overdose response and structural vulnerabilities among harm reduction workers in community settings G Kolla, C Strike International Journal of Drug Policy 74, 127-135, 2019 | 86 | 2019 |
| ‘It's our safe sanctuary’: Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario A Foreman-Mackey, AM Bayoumi, M Miskovic, G Kolla, C Strike International Journal of Drug Policy 73, 135-140, 2019 | 85 | 2019 |
| Risk creating and risk reducing: Community perceptions of supervised consumption facilities for illicit drug use G Kolla, C Strike, TM Watson, J Jairam, B Fischer, AM Bayoumi Health, Risk & Society 19 (1-2), 91-111, 2017 | 82 | 2017 |
| Police perceptions of supervised consumption sites (SCSs): A qualitative study TM Watson, A Bayoumi, G Kolla, R Penn, B Fischer, J Luce, C Strike Substance Use & Misuse 47 (4), 364-374, 2012 | 67 | 2012 |
| “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm … S Glegg, K McCrae, G Kolla, N Touesnard, J Turnbull, TD Brothers, R Brar, ... International Journal of Drug Policy 106, 103742, 2022 | 64 | 2022 |
| Potential cost‐effectiveness of supervised injection facilities in Toronto and Ottawa, Canada EA Enns, GS Zaric, CJ Strike, JA Jairam, G Kolla, AM Bayoumi Addiction 111 (3), 475-489, 2016 | 64 | 2016 |
| Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic T Gomes, R Murray, G Kolla, P Leece, S Bansal, J Besharah Ontario: Ontario Drug Policy Research Network, 2021 | 62 | 2021 |
| Practices of care among people who buy, use, and sell drugs in community settings G Kolla, C Strike Harm reduction journal 17, 1-12, 2020 | 59 | 2020 |
| Interrupting the social processes linked with initiation of injection drug use: results from a pilot study C Strike, M Rotondi, G Kolla, É Roy, NK Rotondi, K Rudzinski, R Balian, ... Drug and alcohol dependence 137, 48-54, 2014 | 57 | 2014 |
| A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone M Perri, N Kaminski, M Bonn, G Kolla, A Guta, AM Bayoumi, ... Harm reduction journal 18, 1-9, 2021 | 56 | 2021 |
| Increasing public support for supervised injection facilities in O ntario, C anada C Strike, JA Jairam, G Kolla, P Millson, S Shepherd, B Fischer, TM Watson, ... Addiction 109 (6), 946-953, 2014 | 56 | 2014 |
| Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario T Gomes, G Kolla, D McCormack, A Sereda, S Kitchen, T Antoniou CMAJ 194 (36), E1233-E1242, 2022 | 55 | 2022 |
| Critical studies of harm reduction: Overdose response in uncertain political times TM Watson, G Kolla, E van der Meulen, Z Dodd International Journal of Drug Policy 76, 102615, 2020 | 53 | 2020 |
| Preventing injection drug use initiation: state of the evidence and opportunities for the future D Werb, RN Bluthenthal, G Kolla, C Strike, AH Kral, A Uusküla, ... Journal of Urban Health 95, 91-98, 2018 | 52 | 2018 |
| Ambivalence about supervised injection facilities among community stakeholders C Strike, TM Watson, G Kolla, R Penn, AM Bayoumi Harm reduction journal 12, 1-5, 2015 | 51 | 2015 |
| Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada S Young, G Kolla, D McCormack, T Campbell, P Leece, C Strike, ... International Journal of Drug Policy 102, 103601, 2022 | 43 | 2022 |
| Design considerations for supervised consumption facilities (SCFs): preferences for facilities where people can inject and smoke drugs TM Watson, C Strike, G Kolla, R Penn, J Jairam, S Hopkins, J Luce, ... International Journal of Drug Policy 24 (2), 156-163, 2013 | 40 | 2013 |
| The impact of the COVID-19 pandemic on opioid-related harm in Ontario EL Friesen, PA Kurdyak, T Gomes, G Kolla, P Leece, L Zhu, E Toombs, ... Science Briefs of the Ontario COVID-19 Science Advisory Table 2 (42), 1-14, 2021 | 38 | 2021 |
| Transition to injection drug use: the role of initiators NK Rotondi, C Strike, G Kolla, MA Rotondi, K Rudzinski, T Guimond, ... AIDS and Behavior 18, 486-494, 2014 | 38 | 2014 |